Goldman Sachs Initiates Coverage On Mobia Medical with Buy Rating, Announces Price Target of $31

Benzinga Newsdesk www.benzinga.com Neutral 51.4%

Neg 0% Neu 51.4% Pos 0%

Goldman Sachs analyst David Roman initiates coverage on Mobia Medical (NASDAQ:MOBI) with a Buy rating and announces Price Target of $31.